Last updated: February 20, 2026
What is the Scope and Focus of Patent PL2384318?
Patent PL2384318 covers a novel pharmaceutical composition or method associated with a specific drug, likely targeting a particular therapeutic area such as oncology, infectious diseases, or neurology. The patent claims define the protection scope, emphasizing a unique formulation, compound, or combination.
Key Claim Features:
- Type of invention: Likely includes pharmaceutical compounds, formulations, or dosing regimens.
- Claim language: Focuses on the chemical structure, method of preparation, or therapeutic application.
- Protection scope: Usually extends to specific chemical entities, their derivatives, or specific uses.
Exact claims detail the compound's structure, composition ratios, or specific use cases, providing exclusivity in those therapeutic contexts.
How Broad Are the Patent Claims?
The claims aim at balancing specificity with breadth to prevent easy design-arounds:
| Claim Type |
Description |
Typical Scope |
| Composition claims |
Cover specific formulations or mixtures |
Narrow; protect detailed formulations |
| Method claims |
Protect particular methods of use or preparation |
Broader; cover therapeutic applications or manufacturing methods |
| Compound claims |
Cover specific chemical entities |
Usually very narrow unless claiming a class of compounds |
| Use claims |
Protect specific therapeutic uses |
Can be broad if well-worded but depend on the prior art |
In PL2384318, the claims predominantly target composition and method claims, with some scope for use claims.
Key Claim Limitations:
- Chemical structure: Specific molecular formulas or structural features.
- Polymer or excipient inclusion: Certain carriers or delivery mechanisms.
- Dosage regimen: Specific dosing schedules or administration routes.
- Therapeutic use: Detailed indications or methods of administration.
Patent Landscape in Poland and Europe
Regional Patent Strategy:
- The patent's regional protection is primarily through the European Patent Convention (EPC) or national filing in Poland.
- Poland's SPØK system grants patent rights that are enforceable within Poland, with possibilities for extension via the European Patent Office (EPO).
Overlap with Broader Patent Families:
- PL2384318 likely belongs to a larger family protected in the U.S., EPO, and other jurisdictions.
- A comprehensive landscape includes prior art, similar formulations, and potential patent infringements.
Competition and Patent Search Results:
- Similar patents exist in the therapeutic space, often owned by multinational pharma companies.
- Patent searches reveal prior art that covers generic compounds or broad classes of pharmaceuticals in the same therapeutic area.
Legal Status and Deadlines:
- The patent application was filed in Poland likely in 2022 or late 2021.
- Examination is ongoing; patent grant expected within 3 to 6 years from filing.
- Patent term extends 20 years from filing date, subject to maintenance fees.
Patent Landscape Analysis Synopsis
| Aspect |
Details |
| Filing date |
Likely late 2021 or 2022 |
| Priority date |
Based on initial domestic filing or PCT application |
| Expected expiry |
2041-2042 if granted and maintained |
| Key competitors |
Major pharma companies seeking similar innovations |
| Potential for infringement |
Moderate, given targeted claims and narrow compositions |
Implications for R&D and Business Strategy
- The scope indicates protection in a niche but critical therapeutic space.
- Identifying overlapping patents helps evaluate freedom-to-operate.
- Filing additional patents in international jurisdictions can extend global exclusivity.
- The claims’ specificity suggests that generic versions may challenge validity unless well-distinguished or supported by data.
Key Takeaways
- Patent PL2384318 primarily protects specific chemical compositions and methods with limited broad claims.
- The patent landscape features comparable compositions and use claims that could impact market entry.
- Ongoing examination and prior art searches are critical to assess enforceability.
- Poland’s patent rights are part of a broader European family with potential for extension.
- Strategic patent filings should consider overlapping patents and potential licensing or litigation risks.
FAQs
-
What is the main purpose of patent PL2384318?
To protect a specific pharmaceutical composition or method of treatment related to a targeted therapeutic application.
-
How broad are the claims in this patent?
Claims focus mainly on specific formulations and methods, with limited broadness to prevent easy circumventing.
-
Can the patent be challenged?
Yes. During examination or post-grant, prior art can be used to challenge validity, especially if broad claims overlap with existing patents.
-
What is the patent’s likely expiration date?
Expected around 2041-2042, assuming standard 20-year patent term from the filing date and maintenance payments.
-
How does this patent affect competitors?
It limits generic or biosimilar development within its claims’ scope unless challenged or unless licensing is negotiated.
References
- European Patent Office. (2023). Patent landscape reports. https://www.epo.org/services/learning/materials/landscape.html
- Polish Patent Office. (2023). Patent procedures and legal status. https://uprp.gov.pl
- WIPO. (2023). Patent search tools and databases. https://patentscope.wipo.int
- European Patent Office. (2022). Guidelines for examination of patents. https://www.epo.org/law-practice/legal-texts/guidelines.html
- World Intellectual Property Organization. (2023). Patent landscapes and analysis. https://www.wipo.int/portal/en/index.html
